JCI - Citations to Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice.

Citations to this article

Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice.

I A Heijnen, … , J S Verbeek, J G van de Winkel

I A Heijnen, … , J S Verbeek, J G van de Winkel

Published January 15, 1996
Citation Information: J Clin Invest. 1996;97(2):331-338. https://doi.org/10.1172/JCI118420.

View: Text | PDF

Research Article

Total citations by year

Year:	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	Total
Citations:	1	1	3	3	2	1	2	4	4	3	16	3	7	2	2	4	9	6	8	5	7	5	3	14	7	6	7	8	2	145

Citation information

Citations to this article (145)

Title and authors	Publication	Year
Antibody-mediated control mechanisms of viral infections Mackin SR, Sariol A, Diamond MS	Immunological reviews	2024
SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines. Sunagar R, Singh A, Kumar S	Human vaccines	2023
Novel Human FCGR1A Variants Affect CD64 Functions and Are Risk Factors for Sarcoidosis. Wu J, Li Y, Rendahl A, Bhargava M	Frontiers in immunology	2022
Skin Treatment with Detergent Induces Dermatitis with H1-Antihistamine-Refractory Itch and Upregulates IL-4 and Th17/Th22 Cytokine Gene Expression in C57BL/6 Mice. Masutani Y, Takai T, Kamijo S, Kimitsu T, Yoshimura T, Ichikawa S, Shimizu S, Ogawa T, Takada K, Tominaga M, Suto H, Takamori K, Ogawa H, Okumura K, Ikeda S	International Archives of Allergy and Immunology	2022
THP-1 cells transduced with CD16A utilize Fcγ receptor I and III in the phagocytosis of IgG-sensitized human erythrocytes and platelets. Gil Gonzalez L, Fernandez-Marrero Y, Norris PAA, Tawhidi Z, Shan Y, Cruz-Leal Y, Won KD, Frias-Boligan K, Branch DR, Lazarus AH	PloS one	2022
A Novel Recombinant Fcγ Receptor-Targeted Survivin Combines with Chemotherapy for Efficient Cancer Treatment CC Wu, CY Chiang, SJ Liu, HW Chen	Biomedicines	2021
Neutrophils and Influenza: A Thin Line between Helpful and Harmful ST George, J Lai, J Ma, HD Stacey, MS Miller, CE Mullarkey	Human vaccines	2021
Bimodal Targeting of Human Leukocytes by Fc- and CpG-Decorated Polymersomes to Tune Immune Induction LF van Beek, PL Welzen, LU Teufel, I Joosten, DA Diavatopoulos, J van Hest, MI de Jonge	Biomacromolecules	2021
Harnessing the immune system via FcγR function in immune therapy: a pathway to next‐gen mAbs AM Chenoweth, BD Wines, JC Anania, PM Hogarth	Immunology and Cell Biology	2020
Preclinical Efficacy of a Trivalent Human FcγRI-Targeted Adjuvant-Free Subunit Mucosal Vaccine against Pulmonary Pneumococcal Infection S Kumar, R Sunagar, EJ Gosselin	Human vaccines	2020
Delivery of Antigen to CD8+ Dendritic Cells by Fusing Antigen With Formyl Peptide Receptor-Like 1 Inhibitor Protein Induces Antitumor Immunity CY Chiang, CC Wu, YJ Chen, SJ Liu, CH Leng, HW Chen	Frontiers in immunology	2019
Mechanisms of inside-out signaling of the high-affinity IgG receptor FcγRI AM Brandsma, SL Schwartz, MJ Wester, CC Valley, GL Blezer, G Vidarsson, KA Lidke, T ten Broeke, DS Lidke, JH Leusen	Science signaling	2018
Plant-expressed Fc-fusion protein tetravalent dengue vaccine with inherent adjuvant properties MY Kim, A Copland, K Nayak, A Chandele, MS Ahmed, Q Zhang, GR Diogo, MJ Paul, S Hofmann, MS Yang, YS Jang, JK Ma, R Reljic	Plant Biotechnology Journal	2018
The pathophysiology of anaphylaxis LL Reber, JD Hernandez, SJ Galli	Journal of Allergy and Clinical Immunology	2017
Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins U Grawunder, S Barth	Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins	2017
CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases OA Akinrinmade, S Chetty, AK Daramola, M Islam, T Thepen, S Barth	Biomedicines	2017
Single Nucleotide Polymorphisms of the High Affinity IgG Receptor FcγRI Reduce Immune Complex Binding and Downstream Effector Functions AM Brandsma, T Broeke, ED Hollander, TG Caniels, T Kardol-Hoefnagel, J Kuball, JH Leusen	Journal of immunology (Baltimore, Md. : 1950)	2017
Mechanisms of anaphylaxis in human low-affinity IgG receptor locus knock-in mice CM Gillis, F Jönsson, DA Mancardi, N Tu, H Beutier, NV Rooijen, LE Macdonald, AJ Murphy, P Bruhns	Journal of Allergy and Clinical Immunology	2016
Lipidated L2 epitope repeats fused with a single-chain antibody fragment targeting human FcγRI elicited cross-neutralizing antibodies against a broad spectrum of human papillomavirus types T Zhang, H Liu, X Chen, Z Wang, S Wang, C Qu, J Zhang, X Xu	Vaccine	2016
Compendium of Inflammatory Diseases J El-Benna, PM Dang, M Hurtado-Nedelec	Compendium of Inflammatory Diseases	2016
FcγR mediates TLR2- and Syk-dependent NLRP3 inflammasome activation by inactivated Francisella tularensis LVS immune complexes EB Duffy, S Periasamy, D Hunt, JR Drake, JA Harton	Journal of leukocyte biology	2016
SLE-associated risk factors affect DC function M Son, SJ Kim, B Diamond	Immunological Reviews	2015
Mouse and human FcR effector functions P Bruhns, F Jönsson	Immunological Reviews	2015
Elevated Membrane and Soluble CD64: A Novel Marker Reflecting Altered FcγR Function and Disease in Early Rheumatoid Arthritis That Can Be Regulated by Anti-Rheumatic Treatment P Matt, U Lindqvist, S Kleinau, M Kuwana	PloS one	2015
Fc Receptors M Daeron, F Nimmerjahn		2014
Fc Receptors M Daeron, F Nimmerjahn		2014
Fc Receptors M Daeron, F Nimmerjahn		2014
Fc Receptors M Daeron, F Nimmerjahn		2014
Fc Receptors M Daeron, F Nimmerjahn		2014
Fc Receptors M Daeron, F Nimmerjahn		2014
Fc Receptors M Daeron, F Nimmerjahn		2014
Fc Receptors M Daeron, F Nimmerjahn		2014
Fc Receptors M Daeron, F Nimmerjahn		2014
Fc Receptors M Daeron, F Nimmerjahn		2014
The function of Fcγ receptors in dendritic cells and macrophages M Guilliams, P Bruhns, Y Saeys, H Hammad, BN Lambrecht	Nature Reviews Immunology	2014
Fc receptor-targeting of immunogen as a strategy for enhanced antigen loading, vaccination, and protection using intranasally administered antigen-pulsed dendritic cells GH Pham, BV Iglesias, EJ Gosselin	Vaccine	2014
IgG Subclasses and Allotypes: From Structure to Effector Functions G Vidarsson, G Dekkers, T Rispens	Frontiers in immunology	2014
Antibody Fc MA Lindorfer, J Köhl, RP Taylor	Antibody Fc	2014
Contribution of Human FcγRs to Disease with Evidence from Human Polymorphisms and Transgenic Animal Studies C Gillis, A Gouel-Chéron, F Jönsson, P Bruhns	Frontiers in immunology	2014
Anti-tumor activity of human IgG1 anti-gp75 TA99 mAb against B16F10 melanoma in human FcgammaRI transgenic mice P Boross, JH Jansen, G Tetering, M Nederend, A Brandsma, S Meyer, E Torfs, HJ Ham, L Meulenbroek, S Haij, JH Leusen	Immunology Letters	2014
The high-affinity human IgG receptor FcγRI (CD64) promotes IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy DA Mancardi, M Albanesi, F Jönsson, B Iannascoli, NV Rooijen, X Kang, P England, M Daëron, P Bruhns	Blood	2013
Oligomannose-Coated Liposome as a Novel Adjuvant for the Induction of Cellular Immune Responses to Control Disease Status N Kojima, M Ishii, Y Kawauchi, H Takagi	BioMed Research International	2013
Molecular and Cellular Mechanisms of Antibody Activity F Nimmerjahn		2013
Properties of mouse and human IgG receptors and their contribution to disease models P Bruhns	Blood	2012
FcγRI (CD64): an identity card for intestinal macrophages JD Calisto, EJ Villablanca, JR Mora	European Journal of Immunology	2012
Multiple mechanisms mediate enhanced immunity generated by mAb-inactivated F. tularensis immunogen BV Iglesias, C Bitsaktsis, G Pham, JR Drake, KR Hazlett, K Porter, EJ Gosselin	Immunology and Cell Biology	2012
Mechanism of action of therapeutic monoclonal antibodies: promises and pitfalls of in vitro and in vivo assays J Golay, M Introna	Archives of Biochemistry and Biophysics	2012
Physiology of the Gastrointestinal Tract, Two Volume Set PR Kiela, JF Collins, FK Ghishan	Physiology of the Gastrointestinal Tract, Two Volume Set	2012
Development of the Vault Particle as a Platform Technology LH Rome, VA Kickhoefer	ACS Nano	2012
Mouse model recapitulating human Fcγ receptor structural and functional diversity P Smith, DJ DiLillo, S Bournazos, F Li, JV Ravetch	Proceedings of the National Academy of Sciences	2012
Mucosal Immunization with an Unadjuvanted Vaccine That Targets Streptococcus pneumoniae PspA to Human Fcγ Receptor Type I Protects against Pneumococcal Infection through Complement- and Lactoferrin-Mediated Bactericidal Activity C Bitsaktsis, BV Iglesias, Y Li, J Colino, CM Snapper, SK Hollingshead, G Pham, DR Gosselin, EJ Gosselin, A Camilli	Infection and immunity	2011
Bispecific Antibodies RE Kontermann		2011
Cytokine-induced immune complex binding to the high-affinity IgG receptor, Fc RI, in the presence of monomeric IgG CE van der Poel, RA Karssemeijer, P Boross, JA van der Linden, M Blokland, JG van de Winkel, JH Leusen	Blood	2010
CD4 + T Cells and Antibody Are Required for Optimal Major Outer Membrane Protein Vaccine-Induced Immunity to Chlamydia muridarum Genital Infection CM Farris, SG Morrison, RP Morrison	Infection and immunity	2010
Activating and inhibitory Fcγ receptors in immunotherapy: being the actor or being the target R Abès, CA Dutertre, L Agnelli, JL Teillaud	Expert Review of Clinical Immunology	2009
Fc receptor-targeted mucosal vaccination as a novel strategy for the generation of enhanced immunity against mucosal and non-mucosal pathogens EJ Gosselin, C Bitsaktsis, Y Li, BV Iglesias	Archivum Immunologiae et Therapiae Experimentalis	2009
A Vault Nanoparticle Vaccine Induces Protective Mucosal Immunity CI Champion, VA Kickhoefer, G Liu, RJ Moniz, AS Freed, LL Bergmann, D Vaccari, S Raval-Fernandes, AM Chan, LH Rome, KA Kelly, D Unutmaz	PloS one	2009
Utilization of Immunoglobulin G Fc Receptors by Human Immunodeficiency Virus Type 1: a Specific Role for Antibodies against the Membrane-Proximal External Region of gp41 LG Perez, MR Costa, CA Todd, BF Haynes, DC Montefiori	Journal of virology	2009
Neutrophils in antibody-based immunotherapy of cancer M Egmond	Expert Opinion on Biological Therapy	2008
Surfactant protein D/anti-Fc receptor bifunctional proteins as a tool to enhance host defence EC Breij, JJ Batenburg	Expert Opinion on Biological Therapy	2008
Targeting allergen to Fc gammaRI: a strategy to treat allergic disease? KE Hulse, JA Woodfolk	Current Opinion in Allergy and Clinical Immunology	2008
Malaria vaccines: immunity, models and monoclonal antibodies L Hviid, L Barfod	Trends in Parasitology	2008
Immune opsonins modulate BLyS/BAFF release in a receptor-specific fashion* X Li, K Su, C Ji, AJ Szalai, J Wu, Y Zhang, T Zhou, RP Kimberly, JC Edberg	Journal of immunology (Baltimore, Md. : 1950)	2008
Utilization of Fc Receptors as a Mucosal Vaccine Strategy against an Intracellular Bacterium, Francisella tularensis1 DB Rawool, C Bitsaktsis, Y Li, DR Gosselin, Y Lin, NV Kurkure, DW Metzger, EJ Gosselin	Journal of immunology (Baltimore, Md. : 1950)	2008
Filamin A Stabilizes FcγRI Surface Expression and Prevents Its Lysosomal Routing JM Beekman, CE van der Poel, JA van der Linden, DL van den Berg, PV van den Berghe, JG van de Winkel, JH Leusen	Journal of immunology (Baltimore, Md. : 1950)	2008
Immune Opsonins Modulate BLyS/BAFF Release in a Receptor-Specific Fashion X Li, K Su, C Ji, AJ Szalai, J Wu, Y Zhang, T Zhou, RP Kimberly, JC Edberg	Journal of immunology (Baltimore, Md. : 1950)	2008
Utilization of Fc Receptors as a Mucosal Vaccine Strategy against an Intracellular Bacterium, Francisella tularensis DB Rawool, C Bitsaktsis, Y Li, DR Gosselin, Y Lin, NV Kurkure, DW Metzger, EJ Gosselin	Journal of immunology (Baltimore, Md. : 1950)	2008
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting PJ Tacken, IJ de Vries, R Torensma, CG Figdor	Nature Reviews Immunology	2007
Prostaglandin E2 modulates dendritic cell function during chlamydial genital infection W Liu, KA Kelly	Immunology	2007
A novel Fcγ receptor ligand augments humoral responses by targeting antigen to Fcγ receptors MA Jensen, BG Arnason, DM White	European Journal of Immunology	2007
Enhanced transduction of dendritic cells by FcγRI-targeted adenovirus vectors R Sapinoro, CA Maguire, A Burgess, S Dewhurst	The Journal of Gene Medicine	2007
The Biology of Dendritic Cells and HIV Infection S Gessani, F Belardelli		2007
The Importance of Human FcγRI in Mediating Protection to Malaria RS McIntosh, J Shi, RM Jennings, JC Chappel, TF de Koning-Ward, T Smith, J Green, M van Egmond, JH Leusen, M Lazarou, J van de Winkel, TS Jones, BS Crabb, AA Holder, RJ Pleass, J Kazura	PLoS pathogens	2007
CD64-directed immunotoxin inhibits arthritis in a novel CD64 transgenic rat model AJ van Vuuren, JA van Roon, V Walraven, I Stuij, MC Harmsen, PM McLaughlin, JG van de Winkel, T Thepen	Journal of immunology (Baltimore, Md. : 1950)	2006
Monocyte CD64 or CD89 targeting by surfactant protein D/anti-Fc receptor mediates bacterial uptake PJ Tacken, JJ Batenburg	Immunology	2006
Direct targeting of genetically modified tumour cells to FcγRI triggers potent tumour cytotoxicity L Bevaart, J Goldstein, L Vitale, C Russoniello, J Treml, J Zhang, RF Graziano, JH Leusen, JG Winkel, T Keler	British Journal of Haematology	2006
Combination vaccines: design strategies and future trends JU Igietseme, FO Eko, Q He, CM Black	Expert Review of Vaccines	2006
Targeting antigens to dendritic cells in vivo PJ Tacken, R Torensma, CG Figdor	Immunobiology	2006
Direct targeting of genetically modified tumour cells to Fc gammaRI triggers potent tumour cytotoxicity L Bevaart, J Goldstein, L Vitale, C Russoniello, J Treml, J Zhang, RF Graziano, JH Leusen, JG van de Winkel, T Keler	British Journal of Haematology	2006
Characterization of an FcγRI-binding peptide selected by phage display G Berntzen, OH Brekke, SA Mousavi, JT Andersen, TE Michaelsen, T Berg, I Sandlie, V Lauvrak	Protein Engineering Design and Selection	2006
Protein Kinase Bα Is Required for Vesicle Trafficking and Class II Presentation of IgA Fc Receptor (CD89)-Targeted Antigen GA Lang, ML Lang	Journal of immunology (Baltimore, Md. : 1950)	2006
The potential of exosomes in immunotherapy N Chaput, J Taïeb, F André, L Zitvogel	Expert Opinion on Biological Therapy	2005
IgG3-Mediated Enhancement of the Antibody Response is Normal in FcgammaRI-Deficient Mice F Hjelm, F Carlsson, S Verbeek, B Heyman	Scandinavian Journal of Immunology	2005
Regulation of B-Cell Activation by Complement Receptors and Fc Receptors CH Nielsen, RG Leslie	Transfusion Medicine and Hemotherapy	2005
Delivery ofChlamydiavaccines J Igietseme, F Eko, Q He, C Bandea, W Lubitz, A Garcia-Sastre, C Black	Expert Opinion on Drug Delivery	2005
Enhanced Antigen-Specific Antibody and Cytokine Responses When Targeting Antigen to Human FcGAMMA Receptor Type I Using an Anti-Human FcGAMMA Receptor Type I-Streptavidin Fusion Protein in an Adjuvant-Free System E Adamova, MC Walsh, DR Gosselin, K Hale, MT Preissler, RF Graziano, EJ Gosselin	Immunological Investigations	2005
IgG2a-Mediated Enhancement of Antibody and T Cell Responses and Its Relation to Inhibitory and Activating Fcγ Receptors A Getahun, J Dahlström, S Wernersson, B Heyman	Journal of immunology (Baltimore, Md. : 1950)	2004
Antibody regulation of T-cell immunity: implications for vaccine strategies against intracellular pathogens JU Igietseme, FO Eko, Q He, CM Black	Expert Review of Vaccines	2004
Depletion of synovial macrophages in rheumatoid arthritis by an anti-FcgammaRI-calicheamicin immunoconjugate JA van Roon, JW Bijlsma, JG van de Winkel, FP Lafeber	Annals of the rheumatic diseases	2004
Direct interaction between FcgammaRI (CD64) and periplakin controls receptor endocytosis and ligand binding capacity JM Beekman, JE Bakema, JG van de Winkel, JH Leusen	Proceedings of the National Academy of Sciences	2004
IgG- and IgE-mediated antigen presentation on MHC class II A Getahun, B Heyman	Immunology Letters	2004
Modulation of FcγRI (CD64) Ligand Binding by Blocking Peptides of Periplakin JM Beekman, JE Bakema, J der Linden, B Tops, M Hinten, M Vugt, JG van de Winkel, JH Leusen	The Journal of biological chemistry	2004
Handbook of Cancer Vaccines MA Morse, TM Clay, HK Lyerly		2004
Contemporary approaches to designing and evaluating vaccines against Chlamydia JU Igietseme, FO Eko, CM Black	Expert Review of Vaccines	2003
A two-component modular approach for enhancing T-cell activation utilizing a unique anti-FcγRI-streptavidin construct and microspheres coated with biotinylated-antigen MC Walsh, JA Banas, SP Mudzinski, MT Preissler, RF Graziano, EJ Gosselin	Biomolecular Engineering	2003
Selective elimination of synovial inflammatory macrophages in rheumatoid arthritis by an Fc? receptor I-directed immunotoxin JA Roon, AJ Vuuren, S Wijngaarden, KM Jacobs, JW Bijlsma, FP Lafeber, T Thepen, JG Winkel	Arthritis & Rheumatism	2003
New Trends in Cancer for the 21stCentury A Llombart-Bosch, V Felipo		2003
Unique Monoclonal Antibodies Define Expression of FcγRI on Macrophages and Mast Cell Lines and Demonstrate Heterogeneity Among Subcutaneous and Other Dendritic Cells PS Tan, AL Gavin, N Barnes, DW Sears, D Vremec, K Shortman, S Amigorena, PL Mottram, PM Hogarth	Journal of immunology (Baltimore, Md. : 1950)	2003
C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcgammaRI) KB Bodman-Smith, AJ Melendez, I Campbell, PT Harrison, JM Allen, JG Raynes	Immunology	2002
Immune complex–mediated antigen presentation induces tumor immunity K Rafiq, A Bergtold, R Clynes	Journal of Clinical Investigation	2002
Enhanced killing of B lymphoma cells by granulocyte colony-stimulating factor-primed effector cells and Hu1D10 - a humanized human leucocyte antigen DR antibody B Stockmeyer, M Schiller, R Repp, HM Lorenz, JR Kalden, M Gramatzki, T Valerius	British Journal of Haematology	2002
Neutrophil Fc gamma RI as target for immunotherapy of invasive candidiasis A B van Spriel, I E van den Herik-Oudijk, J G van de Winkel	Journal of immunology (Baltimore, Md. : 1950)	2001
Subcutaneous Administration of Interleukin-2 Triggers Fcγ Receptor I Expression on Human Peripheral Blood Neutrophils in Solid and Hematologic Malignancies G Sconocchia, NY Cococcetta, L Campagnano, S Amadori, B Iorio, V Boffo, V Ferdinandi, ID Principe, D Adorno, CU Casciani	Journal of Immunotherapy	2001
Role of Activatory FcγRI and FcγRIII and Inhibitory FcγRII in Inflammation and Cartilage Destruction during Experimental Antigen-Induced Arthritis PL van Lent, K Nabbe, AB Blom, AE Holthuysen, A Sloetjes, LB van de Putte, S Verbeek, WB van Berg	The American Journal of Pathology	2001
MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells X Zhu, G Meng, BL Dickinson, X Li, E Mizoguchi, L Miao, Y Wang, C Robert, B Wu, PD Smith, WI Lencer, RS Blumberg	Journal of immunology (Baltimore, Md. : 1950)	2001
Role of activatory Fc gamma RI and Fc gamma RIII and inhibitory Fc gamma RII in inflammation and cartilage destruction during experimental antigen-induced arthritis PL van Lent, K Nabbe, AB Blom, AE Holthuysen, A Sloetjes, LB van de Putte, S Verbeek, WB van Berg	The American Journal of Pathology	2001
Cancer immunotherapy: insights from transgenic animal models PM McLaughlin, BJ Kroesen, MC Harmsen, LF de Leij	Critical Reviews in Oncology/Hematology	2001
Bispecific antibody-targeted phagocytosis of HER-2/neu expressing tumor cells by myeloid cells activated in vivo PK Wallace, PA Kaufman, LD Lewis, T Keler, AL Givan, JL Fisher, MG Waugh, AE Wahner, PM Guyre, MW Fanger, MS Ernstoff	Journal of Immunological Methods	2001
Introduction: bispecific antibodies DM Segal, GJ Weiner, LM Weiner	Journal of Immunological Methods	2001
Mechanisms of G-CSF- or GM-CSF-stimulated tumor cell killing by Fc receptor-directed bispecific antibodies B Stockmeyer, D Elsässer, M Dechant, R Repp, M Gramatzki, MJ Glennie, JG van de Winkel, T Valerius	Journal of Immunological Methods	2001
Cytotoxicity of Anti-CD64-Ricin A Chain Immunotoxin Against Human Acute Myeloid Leukemia Cells In Vitro and in SCID Mice RK Zhong, JG de Winkel, T Thepen, LD Schultz, ED Ball	Journal of Hematotherapy & Stem Cell Research	2001
Mac-1 (CD11b/CD18) is essential for Fc receptor–mediated neutrophil cytotoxicity and immunologic synapse formation AB van Spriel, JH Leusen, M van Egmond, HB Dijkman, KJ Assmann, TN Mayadas, JG van de Winkel	Blood	2001
Colocalization of FcγRI-Targeted Antigen With Class I MHC: Implications for Antigen Processing CA Guyre, ME Barreda, SL Swink, MW Fanger	Journal of immunology (Baltimore, Md. : 1950)	2001
Protein tyrosine phosphatase εC selectively inhibits interleukin-6– and interleukin- 10–induced JAK-STAT signaling N Tanuma, H Shima, K Nakamura, K Kikuchi	Blood	2001
Receptor Modulation by FcγRI-Specific Fusion Proteins Is Dependent on Receptor Number and Modified by IgG CA Guyre, T Keler, SL Swink, LA Vitale, RF Graziano, MW Fanger	Journal of immunology (Baltimore, Md. : 1950)	2001
Targeting weak antigens to CD64 elicits potent humoral responses in human CD64 transgenic mice T Keler, PM Guyre, LA Vitale, K Sundarapandiyan, JG van de Winkel, YM Deo, RF Graziano	Journal of immunology (Baltimore, Md. : 1950)	2000
Immunotherapeutic perspective for bispecific antibodies AB van Spriel, HH van Ojik, JG van de Winkel	Immunology Today	2000
Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy B Stockmeyer, M Dechant, M Egmond, AL Tutt, K Sundarapandiyan, RF Graziano, R Repp, JR Kalden, M Gramatzki, MJ Glennie, JG van de Winkel, T Valerius	Journal of immunology (Baltimore, Md. : 1950)	2000
Resolution of cutaneous inflammation after local elimination of macrophages T Thepen, AJ van Vuuren, RC Kiekens, CA Damen, WC Vooijs, JG van de Winkel	Nature Biotechnology	2000
Macrophages and cutaneous inflammation TS McCormick, SR Stevens, K Kang	Nature Biotechnology	2000
Immune Complex and Fc Receptor-Mediated Augmentation of Antigen Presentation for in Vivo Th Cell Responses Y Hamano, H Arase, H Saisho, T Saito	Journal of immunology (Baltimore, Md. : 1950)	2000
Therapeutic efficacy of FcγRI/CD64-directed bispecific antibodies in B-cell lymphoma J Honeychurch, AL Tutt, T Valerius, IA Heijnen, JG de Winkel, MJ Glennie	Blood	2000
On the role of complement and Fc γ-receptors in the Arthus reaction J Köhl, JE Gessner	Molecular Immunology	1999
GM-CSF as adjuvant for immunotherapy with bispecific antibodies D Elsässer	European Journal of Cancer	1999
Influence of the Human High-Affinity IgG Receptor FcγRI (CD64) on Residual Infectivity of Neutralized Dengue Virus JJ Schlesinger, SE Chapman	Virology	1999
Human Immunoglobulin A Receptor (FcRI, CD89) Function in Transgenic Mice Requires Both FcR γ Chain and CR3 (CD11b/CD18) M van Egmond, AJ van Vuuren, HC Morton, AB van Spriel, L Shen, FM Hofhuis, T Saito, TN Mayadas, JS Verbeek, JG van de Winkel	Blood	1999
The FcγRIa (CD64) Ligand Binding Chain Triggers Major Histocompatibility Complex Class II Antigen Presentation Independently of Its Associated FcR γ-Chain MJ van Vugt, MJ Kleijmeer, T Keler, I Zeelenberg, MA van Dijk, JH Leusen, HJ Geuze, JG van de Winkel	Blood	1999
Interleukin-10 (IL-10) Selectively Enhances CIS3/SOCS3 mRNA Expression in Human Neutrophils: Evidence for an IL-10–Induced Pathway That Is Independent of STAT Protein Activation MA Cassatella, S Gasperini, C Bovolenta, F Calzetti, M Vollebregt, P Scapini, M Marchi, R Suzuki, A Suzuki, A Yoshimura	Blood	1999
IFN-γ induces the high-affinity Fc receptor I for IgG (CD64) on human glomerular mesangial cells P Uciechowski, M Schwarz, JE Gessner, RE Schmidt, K Resch, HH Radeke	European Journal of Immunology	1998
MUC1 cross-reactive Galα(l,3)Gal antibodies in humans switch immune responses from cellular to humoral V Apostolopoulos, C Osinski, IF Mckenzie	Nature Medicine	1998
Regulation of murine hypersensitive responses by Fc receptors T Takai, M Ono, A Ujike, T Yuasa	Allergology International	1998
The neutrophil: one of the cellular targets of interleukin-10 MA Cassatella	International Journal of Clinical & Laboratory Research	1998
Macrophage-targeted killing and vaccines CA Guyre, MW Fanger	Research in Immunology	1998
The second and third extracellular domains of Fc γ RI (CD64) confer the unique high affinity binding of IgG2a MD Hulett, PM Hogarth	Molecular Immunology	1998
The Immunoglobulin Receptors and their Physiological and Pathological Roles in Immunity JG van de Winkel, PM Hogarth		1998
Fc Receptors as Targets for Immunotherapy H Rouard, S Tamasdan, J Moncuit, S Moutel, J Michon, WH Fridman, JL Teillaud	International Reviews of Immunology	1997
Human IgG Fc Receptors IA Heijnen, JG van de Winkel	International Reviews of Immunology	1997
Structural Bases of FcγR Functions M Daéron	International Reviews of Immunology	1997
FcRECEPTOR BIOLOGY M Daëron	Annual Review of Immunology	1997
Bispecific antibodies for the treatment of tumours and infectious diseases DL Drakeman, MW Fanger, PK Wallace	Expert Opinion on Investigational Drugs	1997
Clinical significance of IgG Fc receptors and FcγR-directed immunotherapies YM Deo, RF Graziano, R Repp, JG van de Winkel	Immunology Today	1997
Natural anti-Gal antibody as a universal augmenter of autologous tumor vaccine immunogenicity U Galili, DC LaTemple	Immunology Today	1997
FcαRI (CD89) as a Novel Trigger Molecule for Bispecific Antibody Therapy T Valerius, B Stockmeyer, AB van Spriel, RF Graziano, IE van den Herik-Oudijk, R Repp, YM Deo, J Lund, JR Kalden, M Gramatzki, JG van de Winkel	Blood	1997
F(c)gammaRI-targeted fusion proteins result in efficient presentation by human monocytes of antigenic and antagonist T cell epitopes C Liu, J Goldstein, RF Graziano, J He, JK O'Shea, Y Deo, PM Guyre	Journal of Clinical Investigation	1996
Cell-Mediated Effects of Immunoglobulins WH Fridman, C Sautès		1996

Advertisement